|
|
Splendors of Southern Europe Cruise: Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
CME/CE Lecture Seminars for Medical, Dental, Nursing, and Allied Healthcare Professionals
This Seminar is planned for 12 Continuing Education Credit Hours.
CME/CE Professional Seminar Fee: $695
Seminar Attendance Fee: $450
CME/CE credits, Certificates of Completion and possible tax deductible guidelines will be provided for registered Professional Seminar attendees Certificates of Attendance will be provi... |
|
|
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
Content Source
This continuing education (CE) activity captures content from a virtual roundtable discussion.
Activity Description
Based on a roundtable discussion in August, this supplement summarizes the challenges facing clinicians when managing diabetic eye disease and wet age-related macular degeneration (AMD) and the current and pipeline therapy options for these diseases.
Target Audience
This certified CE activity is designed for optometrists who care for patients with di... |
|
|
Treating Presbyopia: New Approaches to a Familiar Problem
Content Source
This continuing medical education (CE/CME) activity captures content from a live symposium at ASCRS.
Activity Description
Based on a live symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on how to manage presbyopic changes with a variety of current and newly emerging treatment options, and how strategies may work synergistically.
Target Audience
This certified continuing me... |
|
|
Ocular Manifestations of Infectious Diseases in Children
Since the onset of the COVID-19 pandemic, national vaccination rates have dropped significantly, and there is concern about a potential rise in vaccine-preventable diseases (VPDs), especially in children. As members of the healthcare community, eye care providers should recognize that vaccines are the best way to protect themselves and their families, as well as their patients and coworkers. This webinar focuses on various systemic and ocular presentations of infectious diseases, with a focus ... |
|
|
Modern Medical Glaucoma Exploring the Trends
This webcast focuses on the newest therapies in glaucoma management and how their mechanisms of action and efficacy compares to traditional prostaglandins. The webcast also includes case discussions. Please also enjoy the perviously recorded question-and-answer session with Drs. Ian Benjamin Gaddie and Gagan Sawhney! |
|
|
Community Practice Connections™: Expert Approaches in Cataract Surgery " Managing Advances in Techniques and Technologies With an Updated Armamentarium - COPE
Target Audience
This online educational activity is directed toward ophthalmologists and other health care professionals involved in the management of patients with cataracts.
Activity Overview
Surgical removal of cataracts and implantation with intraocular lenses (IOLs) is an increasingly common procedure. The growing variety of pre- and intraoperative surgical devices and IOLs is expanding options for both patients and clinicians. Appropriate technique and IOL selection for each patient... |
|
|
MGD-Associated Dry Eye Disease " How Emerging Options May Shift the Treatment Paradigm (COPE)
Target Audience
The target audience for this activity is optometrists and other health care professionals who are involved in the management of patients with MGD-associated DED.
Activity Overview
Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the u... |
|
|
Neurotrophic Keratitis: Managing a Sensitive Issue
Neurotrophic keratitis (NK) is a rare degenerative corneal disease that if left untreated can lead to infection, ulceration, stromal melting, perforation secondary to poor healing, and vision loss. Patients with early stages of NK may experience few symptoms, which makes diagnosis challenging and potentially puts them at risk for epithelial damage, as seen in later stages of disease. Testing to evaluate reduced corneal sensitivity and nerve damage is imperative in diagnosing NK. Current and em... |
|
|
Expert Illustrations & Commentaries™: Visualizing Cornea l Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis
Target Audience
This educational activity is directed toward ophthalmologists, optometrists, and other health care professionals who would be involved in treating NK.
Program Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient with NK will share her experiences. Expert faculty will share commentary on NK etiolo... |
|
|
Expert Illustrations & Commentaries™: Visualizing Cornea l Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis
Target Audience
This educational activity is directed toward ophthalmologists, optometrists, and other health care professionals who would be involved in treating NK.
Program Overview
This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient with NK will share her experiences. Expert faculty will share commentary on NK etiolo... |
|
|
Uveitic Macular Edema: Assessing Diagnostic Patterns and Treatment Options That Can Keep This Complication Out of Sight
Inflammation of the uvea"or uveitis"is conducive to about 10% of blindness in people in the United States. Approximately 80% of uveitis is noninfectious in etiology, imposing a substantial socioeconomic impact to affected patients and the US health care system every year. A prominent complication is uveitic macular edema (UME), which affects up to 30% of all patients regardless of etiology and is the leading cause of blindness in patients with uveitis. Establishing the correct diagno... |
|
|
Stump the Provider: A 27-Year-Old Man With Blurred Vision in the Right Eye
In this article, Dr. Jeng reviews approaches to diagnosis and management of ocular surface disease in a contact lens wearer experiencing blurred vision. |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Summaries of Clinical Trials
Therapeutic and surgical algorithms for the management and treatment of patients with retinal diseases continue to evolve, while management protocols are being further refined in light of real-world outcomes. Recognizing and understanding these evidence-based treatment advances are imperative to enhance treatment outcomes; however, staying up-to-date with the latest evidence from clinical trials as well as emerging diagnostic and treatment options can be challenging. To address these ongoing n... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease - Focus on Age-related Macular Degeneration
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease - Focus on Diabetic Retinopathy
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease " Focus on Diabetic Macular Edema
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Real World Retina: Challenges in the Management of Retinal Disease " Focus on Retinal Vein Occlusion
Real-world outcomes of patients with retinal diseases treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often suboptimal when compared to the results demonstrated in pinnacle clinical studies. The discrepancies in outcomes have in part been attributed to patients receiving fewer than the recommended number of anti-VEGF injections, as well as patients discontinuing therapy due to treatment burden associated with frequent dosing schedules. New imaging techniq... |
|
|
Thyroid Eye Disease: Addressing the Need for Early Intervention and Comanagement
Thyroid eye disease (TED) is a multifactorial, autoimmune disorder with a wide spectrum of signs and symptoms. It is frequently misdiagnosed, due to both the heterogeneous clinical presentation and a failure on the part of clinicians to understand the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at increased risk for complications; however, a differential diagnosis can be achieved with the assistance of imaging. Early diagnosis and treatment can limit disfigure... |
|
|
A Practical Roadmap for Diagnosing and Treating DED, With Drs. Lisa Nijm and Vance Thompson
In this educational podcast, faculty lay out a practical road map for diagnosing and treating dry eye disease using the currently available diagnostic tools and therapeutics. |
|
|
In Case You Missed: Advancing Science in the Management of Demodex Blepharitis
Recent US studies have reported Demodex blepharitis infestation rates of 55% to 58% in eye care clinical patients. However, patients with Demodex blepharitis may go undiagnosed or misdiagnosed due to overlapping symptoms seen in dry eye disease and other ocular surface or lid margin disorders. Treatment can also be challenging as there are currently no FDA-approved therapies and most conventional options treat the symptoms of disease but not the underlying cause. Emerging therapeutic options a... |
|
|
Surgical Solutions to Achieve and Maintain Visual Gains in nAMD
Management of patients with retinal vascular diseases utilizing intravitreal anti-vascular endothelial growth factor (VEGF) therapy has provided significant enhancements to visual acuity outcomes, but maintenance of these visual acuity gains requires frequent treatment and monitoring. The frequency of these clinical visits can be a challenge to sustain and places a considerable burden on the patient and caregivers―often resulting in undertreatment of disease due to loss of adherence. To addr... |
|
|
Surgical Solutions to Achieve and Maintain Visual Gains in nAMD
Management of patients with retinal vascular diseases utilizing intravitreal anti-vascular endothelial growth factor (VEGF) therapy has provided significant enhancements to visual acuity outcomes, but maintenance of these visual acuity gains requires frequent treatment and monitoring. The frequency of these clinical visits can be a challenge to sustain and places a considerable burden on the patient and caregivers―often resulting in undertreatment of disease due to loss of adherence. To addr... |
|
|
Extending the Span of Time in nAMD and DME Management
Intravitreal anti-vascular endothelial growth factor (VEGF) therapies have significantly enhanced visual and anatomical outcomes for patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). However, real-world outcomes are not always comparable to those demonstrated in pinnacle clinical studies, in part due to treatment burden and lack of patient adherence. Corticosteroids are another effective therapeutic option for those patients with DME, but these... |
|
|
Thyroid Eye Disease: Cause, Effect, and Treatment Options
The heterogenous presentation of thyroid eye disease (TED) can commonly result in an initial misdiagnosis leading to delays in the initiation of appropriate treatment. Adding to this complexity, the severity of TED can also be quite variable, making early diagnosis challenging. Management of this disease is defined by the phase of disease with the inactive phase usually being treated surgically. Systemic immunosuppression with corticosteroids with or without orbital radiotherapy has traditiona... |
|
|
Dry Eye and Sustained Release Therapies
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following c... |
|
|
Pediatric Influenza: Managing the Comeback Kid
Influenza places a substantial burden on the health of people in the United States each year, with varying impacts. In healthy children, influenza typically is self-limited and uncomplicated, but it can lead to severe morbidity and mortality in those at increased risk for severe or complicated illness. Data show that early antiviral treatment can reduce the duration of illness as well as the risk for complications. Studies have also demonstrated the efficacy of antiviral therapy for post-expos... |
|
|
Ocular Surface Disease: Etiologies and Treatment Modalities
This continuing medical education (CME/CE) activity captures content from a roundtable discussion. ACTIVITY DESCRIPTION Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. This activity will help to inform clinicians on methods to improve the care of patients with DED. T... |
|
|
Eyeing Up the New World Order of Injectables in nAMD and DME Management
Outcomes from pinnacle clinical studies and real-world studies evaluating the management of patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often not comparable. These discrepancies, in part, have been associated with treatment burden and a lack of patient adherence. The refinement of treatment protocols with FDA-approved therapies that extend the interval between d... |
|
|
Eyeing Up the New World Order of Injectables in nAMD and DME Management
Outcomes from pinnacle clinical studies and real-world studies evaluating the management of patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with intravitreal anti-vascular endothelial growth factor (VEGF) therapies are often not comparable. These discrepancies, in part, have been associated with treatment burden and a lack of patient adherence. The refinement of treatment protocols with FDA-approved therapies that extend the interval between d... |
|
|
MIGS and Meds in Glaucoma Management: Applying Evidence to Practice
Glaucoma remains a serious threat to vision, despite various treatment options. Advances in the understanding of aqueous humor outflow mechanisms have contributed to the development of more effective techniques for the management of intraocular pressure (IOP), but controversies remain. A growing number of procedures that avoid conjunctival dissection, collectively termed minimally invasive glaucoma surgery (MIGS), offer alternatives to trabeculectomy for patients who would benefit from IOP low... |
|
|
MIGS and Meds in Glaucoma Management: Applying Evidence to Practice
Glaucoma remains a serious threat to vision, despite various treatment options. Advances in the understanding of aqueous humor outflow mechanisms have contributed to the development of more effective techniques for the management of intraocular pressure (IOP), but controversies remain. A growing number of procedures that avoid conjunctival dissection, collectively termed minimally invasive glaucoma surgery (MIGS), offer alternatives to trabeculectomy for patients who would benefit from IOP low... |
|
|
The Rise of New Regimens in nAMD and DME Management
The standard-of-care treatment for patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) is intravitreal anti-vascular endothelial growth factor (VEGF) therapy. Although most patients receiving these therapies experience significant visual acuity gains, a proportion remain suboptimal in their response. In addition, the frequency of dosing required to maintain initial visual outcomes can be challenging to maintain, resulting in undertreatment of disea... |
|
|
The Rise of New Regimens in nAMD and DME Management
The standard-of-care treatment for patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) is intravitreal anti-vascular endothelial growth factor (VEGF) therapy. Although most patients receiving these therapies experience significant visual acuity gains, a proportion remain suboptimal in their response. In addition, the frequency of dosing required to maintain initial visual outcomes can be challenging to maintain, resulting in undertreatment of disea... |
|
|
The Promise of Nerve Growth Factor Therapy: Managing Neurotrophic Keratitis and Beyond
The early diagnosis and management of neurotrophic keratitis (NK) is imperative to avoid complications such as ulceration, infection, stromal melting, perforation secondary to poor healing, and vision loss. Diagnosis of the early stages of NK can be challenging because patients typically experience few symptoms, which leads to delays in management initiation and the potential for epithelial damage. Current and emerging treatment options―when integrated optimally into management protocols―r... |
|
|
Improving Ocular Surface and Eyelid Health in Today’s Environment
Ocular surface diseases (OSD) are highly prevalent but frequently underdiagnosed and undertreated disorders of the cornea, conjunctiva, and meibomian glands. The spectrum of OSD includes dry eye disease, blepharitis, and meibomian gland dysfunction. These disorders can significantly affect patients’ quality of life, work, and daily activities, and also contribute to suboptimal outcomes from ocular surgery. As our understanding of the risk factors and underlying mechanisms of these conditions... |
|
|
Improving Ocular Surface and Eyelid Health in Today’s Environment
Ocular surface diseases (OSD) are highly prevalent but frequently underdiagnosed and undertreated disorders of the cornea, conjunctiva, and meibomian glands. The spectrum of OSD includes dry eye disease, blepharitis, and meibomian gland dysfunction. These disorders can significantly affect patients’ quality of life, work, and daily activities, and also contribute to suboptimal outcomes from ocular surgery. As our understanding of the risk factors and underlying mechanisms of these conditions... |
|
|
Highlights From Thyroid Eye Disease Forum: Drilling Down and Digging Deeper to Ensure Early Diagnosis and Treatment
Thyroid eye disease (TED) is an autoimmune disorder believed to result from the stimulation of several receptors located in the orbital fibroblasts. It is frequently misdiagnosed, due to both its heterogeneous clinical presentation and a failure on the part of clinicians to understand the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at risk, as management of TED is most effective during the initial, active phase of the disease. However, differential diagnosis c... |
|
|
“Seeing” Eye Drops Expand the Therapeutic Landscape for Presbyopia
Presbyopia is a universal phenomenon accompanying the aging process. Treatment options for presbyopia are currently limited to corrective lenses or invasive surgical procedures that may not be reversible. Patients who require or desire independence from corrective lenses have limited alternatives. However, a pharmacological alternative"pilocarpine HCl ophthalmic solution 1.25%"was recently approved by the FDA, and several more agents for presbyopia are in development, including CSF-1... |
|
|
Tools & Techniques to Enhance Surgical Efficacy & Efficiency
This series of six webcasts offers insight on various issues that are important to eye care professionals. Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and the... |
|
|
Tools & Techniques to Enhance Surgical Efficacy & Efficiency
This series of six webcasts offers insight on various issues that are important to eye care professionals. Each of the webcasts features individualized content, including how to run an efficient practice while caring for patients in the COVID-19 era; use of high-quality screening, monitoring and imaging devices across eye care subspecialties; thorough discussions on why connectivity and transfer of preoperative data to intraoperative technology is necessary for optimal visual outcomes; and the... |
|
|
Chronic Versus Acute: Rethinking Dry Eye Disease
This continuing education activity (CE) captures content from a virtual roundtable discussion.
ACTIVITY DESCRIPTION
Dry eye disease (DED) is a significant public health issue that threatens patient economic productivity and quality of life. About 16 million Americans have a formal DED diagnosis, but the true incidence is likely much higher because many who are symptomatic may not seek medical care. This supplement addresses this issue and others related to managing DED and providing the ... |
|
|
Neuromyelitis Optica Spectrum Disorder: Management Updates and Challenging Clinical Cases
Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that mainly manifests through recurrent attacks of optic neuritis and longitudinally extensive transverse myelitis. NMOSD is often misdiagnosed in the early stages, but the integration of newer diagnostic criteria may assist in an earlier and more accurate differential diagnosis. Until recently, treatment options for NMOSD have been limited―but several approved biologic thera... |
|
|
Neuromyelitis Optica Spectrum Disorder: Management Updates and Challenging Clinical Cases
Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that mainly manifests through recurrent attacks of optic neuritis and longitudinally extensive transverse myelitis. NMOSD is often misdiagnosed in the early stages, but the integration of newer diagnostic criteria may assist in an earlier and more accurate differential diagnosis. Until recently, treatment options for NMOSD have been limited―but several approved biologic thera... |
|
|
Ocular Surface Health and Surgical Outcomes
Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. This activity will help to inform clinicians on methods to improve the care of patients with DED. |
|
|
OSD: Improving Patient Outcomes Through Collaborative Care
Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. This activity will help to inform clinicians on methods to improve the care of patients with DED. |
|
|
Tracking and Treating Uveitic Macular Edema: A Difficult Dilemma
Uveitic macular edema (UME) has a wide variety of causes. If not appropriately treated, it eventually causes damage to the photoreceptors in the macula, resulting in vision-threatening complications like macular ischemia or macular hole formation. Corticosteroids are the first-line treatment for uveitic inflammation and UME. However, they are not generally considered to be appropriate for long-term treatment due to adverse effects, including increased intraocular pressure and cataract in local... |
|
|
Tracking and Treating Uveitic Macular Edema: A Difficult Dilemma
Uveitic macular edema (UME) has a wide variety of causes. If not appropriately treated, it eventually causes damage to the photoreceptors in the macula, resulting in vision-threatening complications like macular ischemia or macular hole formation. Corticosteroids are the first-line treatment for uveitic inflammation and UME. However, they are not generally considered to be appropriate for long-term treatment due to adverse effects, including increased intraocular pressure and cataract in local... |
|